Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedSci Healthcare Holdings has the GF Score of 79, which implies that the company
is
Likely to have average performance.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes MedSci Healthcare Holdings
is
Likely to have average performance.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
MedSci Healthcare Holdings GF Score Related Terms
HKSE:02415 vs VEEV, BTSG, HQY: GF Score Comparison
For the Health Information Services subindustry, MedSci Healthcare Holdings's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedSci Healthcare Holdings GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's GF Score distribution charts can be found below:
* The bar in red indicates where MedSci Healthcare Holdings's GF Score falls into.
MedSci Healthcare Holdings (HKSE:02415) has a GF Score of 79 as of Jul. 31, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on MedSci Healthcare Holdings and its competitors. This is 295% above median its historical median of 20.00. Over the past decade, MedSci Healthcare Holdings' GF Score has ranged from 4.00 to 84.00.
Is MedSci Healthcare Holdings' GF Score too high?
MedSci Healthcare Holdings' current GF Score of 79 is 295% above median its 10-year median of 20.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 84.00. Overall, MedSci Healthcare Holdings has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' GF Score compare to VEEV and BTSG?
MedSci Healthcare Holdings' GF Score of 79 can be compared against companies in the Healthcare Providers & Services industry. Historically, MedSci Healthcare Holdings' own GF Score has ranged from 4.00 to 84.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on MedSci Healthcare Holdings and its competitors. MedSci Healthcare Holdings's current GF Score is 79, which is 295% above median its own 10-year median of 20.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.44, compared to a current price of HK$0.72 — trading 50% below its estimated fair value. The current GF Score is 79, which is 295% above median its 10-year median of 20.00. MedSci Healthcare Holdings' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current GF Score is 79 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.72 is trading 50% below its estimated GF Value™ of HK$1.44.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
GF Score: 79 (295% above median its 10-year median of 20.00)
GF Value™: HK$1.44 vs. price of HK$0.72 (50% below fair value)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
79GF Score
Get the complete analysis for HKSE:02415
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
